- Market Realist•22 hours ago
Roche’s (RHHBY) human epidermal growth factor receptor 2-positive (or HER2) portfolio includes blockbuster Herceptin along with Perjeta and Kadcyla.
|52wk Range||29.89 - 36.49|
|Day's Range||31.51 - 31.70|
|Avg Vol (3m)||997,731|
As of 3:59 PM EDT. Market closed.